Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted from patent WO2014145025A2, Compound Example 10, has IC50s of [1]. Vimseltinib has certain oral bioavailability[2].
Molecular Weight:
431.49
Purity:
99.94
CAS Number:
[1628606-05-2]
Formula:
C23H25N7O2
Target:
c-Fms,c-Kit
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
